China Resources Pharmaceutical Group Limited (Stock Code: 3320) and its non-wholly-owned subsidiary Dong-E-E-Jiao Company Limited (Stock Code: 000423), listed on the Shenzhen Stock Exchange, disclosed plans for a Health Consumer Products Industrial Park in Dong-E County Economic Development Zone, Liaocheng City of Shandong Province. According to the announcement, the project expects to feature manufacturing facilities for E-Jiao products, warehousing and logistics space, quality inspection hubs, product incubation centers, and other supporting infrastructure.

The proposed site covers approximately 406,800 square meters of land, with a planned construction area of around 151,100 square meters. The construction period is projected to last about 22 months, from on-site commencement to final acceptance. The total investment is anticipated to be approximately RMB1.485 billion, including a fixed asset component of around RMB1.421 billion and an initial working capital of RMB64 million. Dong-E-E-Jiao intends to fund the project from its internal resources.

The investment aligns with Dong-E-E-Jiao’s “1238” strategy, focusing on advancing its pharmaceuticals and health consumer products segments. The plan remains subject to the acquisition of the necessary land, the completion of a definitive construction agreement, and the meeting of all relevant conditions. Shareholders and potential investors are advised to exercise caution in dealings related to the company’s securities.